206 related articles for article (PubMed ID: 37725008)
21. TYK2 kinase activity is required for functional type I interferon responses in vivo.
Prchal-Murphy M; Semper C; Lassnig C; Wallner B; Gausterer C; Teppner-Klymiuk I; Kobolak J; Müller S; Kolbe T; Karaghiosoff M; Dinnyés A; Rülicke T; Leitner NR; Strobl B; Müller M
PLoS One; 2012; 7(6):e39141. PubMed ID: 22723949
[TBL] [Abstract][Full Text] [Related]
22. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
23. Expression patterns of three JAK-STAT pathway genes in feather follicle development during chicken embryogenesis.
Tao Y; Zhou X; Liu Z; Zhang X; Nie Y; Zheng X; Li S; Hu X; Yang G; Zhao Q; Mou C
Gene Expr Patterns; 2020 Jan; 35():119078. PubMed ID: 31759166
[TBL] [Abstract][Full Text] [Related]
24. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase.
Yan H; Piazza F; Krishnan K; Pine R; Krolewski JJ
J Biol Chem; 1998 Feb; 273(7):4046-51. PubMed ID: 9461596
[TBL] [Abstract][Full Text] [Related]
25. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes.
Beadling C; Guschin D; Witthuhn BA; Ziemiecki A; Ihle JN; Kerr IM; Cantrell DA
EMBO J; 1994 Dec; 13(23):5605-15. PubMed ID: 7988557
[TBL] [Abstract][Full Text] [Related]
26. STAM and Hrs interact sequentially with IFN-α Receptor to control spatiotemporal JAK-STAT endosomal activation.
Zanin N; Viaris de Lesegno C; Podkalicka J; Meyer T; Gonzalez Troncoso P; Bun P; Danglot L; Chmiest D; Urbé S; Piehler J; Blouin CM; Lamaze C
Nat Cell Biol; 2023 Mar; 25(3):425-438. PubMed ID: 36797476
[TBL] [Abstract][Full Text] [Related]
27. Noncanonical IFN Signaling, Steroids, and STATs: A Probable Role of V-ATPase.
Johnson HM; Noon-Song E; Ahmed CM
Mediators Inflamm; 2019; 2019():4143604. PubMed ID: 31275057
[TBL] [Abstract][Full Text] [Related]
28. Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway.
Kelly A; Robinson MW; Roche G; Biron CA; O'Farrelly C; Ryan EJ
J Interferon Cytokine Res; 2016 Dec; 36(12):671-680. PubMed ID: 27617757
[TBL] [Abstract][Full Text] [Related]
29. Vanadate facilitates interferon alpha-mediated apoptosis that is dependent on the Jak/Stat pathway.
Gamero AM; Larner AC
J Biol Chem; 2001 Apr; 276(17):13547-53. PubMed ID: 11278370
[TBL] [Abstract][Full Text] [Related]
30. Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism.
Lin RJ; Chang BL; Yu HP; Liao CL; Lin YL
J Virol; 2006 Jun; 80(12):5908-18. PubMed ID: 16731929
[TBL] [Abstract][Full Text] [Related]
31. A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction.
Bisson SA; Page AL; Ganem D
J Virol; 2009 May; 83(10):5056-66. PubMed ID: 19279093
[TBL] [Abstract][Full Text] [Related]
32. Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes.
Vogl C; Flatt T; Fuhrmann B; Hofmann E; Wallner B; Stiefvater R; Kovarik P; Strobl B; Müller M
BMC Genomics; 2010 Mar; 11():199. PubMed ID: 20338026
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
[TBL] [Abstract][Full Text] [Related]
34. Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors.
Mesev EV; Lin AE; Guare EG; Heller BL; Douam F; Adamson B; Toettcher JE; Ploss A
Sci Signal; 2023 Oct; 16(806):eadf5494. PubMed ID: 37816090
[TBL] [Abstract][Full Text] [Related]
35. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
[TBL] [Abstract][Full Text] [Related]
36. Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways.
Zhou Y; Li X; Shen R; Wang X; Zhang F; Liu S; Li D; Liu J; Li P; Yan Y; Dong P; Zhang Z; Wu H; Zhuang L; Chowdhury R; Miller M; Issa M; Mao Y; Chen H; Feng J; Li J; Bai C; He F; Tao W
Front Immunol; 2022; 13():884399. PubMed ID: 35693820
[TBL] [Abstract][Full Text] [Related]
37. Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of Daxx.
Aoki K; Shimoda K; Oritani K; Matsuda T; Kamezaki K; Muromoto R; Numata A; Tamiya S; Haro T; Ishikawa F; Takase K; Yamamoto T; Yumioka T; Miyamoto T; Nagafuji K; Gondo H; Nagafuchi S; Nakayama K; Harada M
Exp Hematol; 2003 Dec; 31(12):1317-22. PubMed ID: 14662340
[TBL] [Abstract][Full Text] [Related]
38. Differential Regulation of Type I and Type III Interferon Signaling.
Stanifer ML; Pervolaraki K; Boulant S
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901970
[TBL] [Abstract][Full Text] [Related]
39. Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium.
Liu YG; Jin SW; Zhang SS; Xia TJ; Liao YH; Pan RL; Yan MZ; Chang Q
Front Immunol; 2024; 15():1338096. PubMed ID: 38495892
[TBL] [Abstract][Full Text] [Related]
40. Intracellular signal transduction of interferon on the suppression of haematopoietic progenitor cell growth.
Kato K; Kamezaki K; Shimoda K; Numata A; Haro T; Aoki K; Ishikawa F; Takase K; Ariyama H; Matsuda T; Miyamoto T; Nagafuji K; Gondo H; Nakayama K; Harada M
Br J Haematol; 2003 Nov; 123(3):528-35. PubMed ID: 14617019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
